Frank Mottola is SVP, Chief Tech. Ops. Officer of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 15,496 shares of SUPN, which is worth approximately $697,320. The most recent transaction as insider was on Mar 14, 2023, when has been sold 4,780 shares (Common Stock) at a price of $35.99 per share, resulting in proceeds of $172,032. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.5K
0% 3M change
88.98% 12M change
Total Value Held $697,320

Frank Mottola Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2023
SELL
Open market or private sale
$172,032 $35.99 p/Share
4,780 Reduced 50.23%
4,737 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
750 Added 7.3%
9,517 Common Stock
Feb 16 2023
SELL
Payment of exercise price or tax liability
$29,171 $38.74 p/Share
753 Reduced 8.42%
8,191 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
-
1,500 Added 14.36%
8,944 Common Stock
FM

Frank Mottola

SVP, Chief Tech. Ops. Officer
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN